Literature DB >> 11680640

The effect of short-term treatment with interferon beta 1a on acute experimental allergic encephalomyelitis.

M Wender1, S Michalak, H Wygladalska-Jernas.   

Abstract

The clinical and histological picture and immunocytochemical expression of some cytokines on infiltrates in the central nervous system of Lewis rats were studied in adult rats in the course of short-term therapy of acute experimental allergic encephalomyelitis with interferon beta 1a (IFN beta 1a). There was established the beneficial effect of the short-term treatment of EAE with IFN beta 1a, applied at the early onset of the experimental disease. The effect of IFN beta 1a on EAE seems likely to be associated with the inhibition of proinflammatory cytokines and stimulation of anti-inflammatory ones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680640

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  7 in total

Review 1.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

Authors:  Cris S Constantinescu; Nasr Farooqi; Kate O'Brien; Bruno Gran
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Authors:  Muriel B Sättler; Sarah K Williams; Clemens Neusch; Markus Otto; Jens R Pehlke; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

3.  Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis.

Authors:  Xiaoping Qi; William W Hauswirth; John Guy
Journal:  Mol Vis       Date:  2007-01-05       Impact factor: 2.367

4.  Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.

Authors:  Natalia Lubina-Dąbrowska; Adam Stepień; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Józef Langfort; Małgorzata Chalimoniuk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-03-15       Impact factor: 4.291

5.  Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis.

Authors:  Shailesh K Shahi; Samantha N Freedman; Alexandra C Murra; Kasra Zarei; Ramakrishna Sompallae; Katherine N Gibson-Corley; Nitin J Karandikar; Joseph A Murray; Ashutosh K Mangalam
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

6.  A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance.

Authors:  Saba I Aqel; Xiaozhi Yang; Emma E Kraus; Jinhua Song; Marissa F Farinas; Erin Y Zhao; Wei Pei; Amy E Lovett-Racke; Michael K Racke; Chenglong Li; Yuhong Yang
Journal:  JCI Insight       Date:  2021-02-22

7.  Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.

Authors:  Denise C Fitzgerald; Zoë Fonseca-Kelly; Melissa L Cullimore; Pegah Safabakhsh; Christiaan J M Saris; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.